Design and synthesis of sodium (.beta.R*,.gamma.S*)-4-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl]thio]-.gamma.-hydroxy-.beta.-methylbenzenebutanoate: a novel, selective, and orally active receptor antagonist of leukotriene D4
- 1 September 1986
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 29 (9) , 1573-1576
- https://doi.org/10.1021/jm00159a003